SOD1 and myeloid sarcoma: This study investigated the effects of vitamin D supplementation on key inflammatory and oxidative stress biomarkers in MS patients, revealing a marked decrease in the inflammatory protein CHI3L1 and oxidative stress markers (MDA, TOS), alongside increases in TAC and enzymatic activity (SOD, CAT, GPx) following an 8‐week intervention.